CS
VTYX

Credit Suisse’s Ventyx Biosciences VTYX Stock Holding History

Credit Suisse’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-43,918
Closed -$108K – 3044
2023
Q4 		$108K Buy
43,918
+5,221
+13% +$49.6K ﹤0.01% 3025
2023
Q3 		$1.34M Buy
38,697
+1,815
+5% +$62.7K ﹤0.01% 2089
2023
Q2 		$1.21M Buy
36,882
+22,798
+162% +$786K ﹤0.01% 2256
2023
Q1 		$472K Buy
14,084
+1,218
+9% +$47.4K ﹤0.01% 2784
2022
Q4 		$422K Buy
12,866
+12,739
+10,031% +$377K ﹤0.01% 2883
2022
Q3 		$4K Buy
127
+110
+647% +$2.44K ﹤0.01% 3657
2022
Q2 		$0 Buy
+17
New +$254 ﹤0.01% 4357

Other funds holding VTYX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Credit Suisse's VTYX Position: Q1 2024 in Review

Credit Suisse sold out of Ventyx Biosciences (VTYX) in Q1 2024, closing a stake of 43,918 shares — an estimated $108K sold.

Credit Suisse first reported a position in VTYX in Q2 2022 and held it in 7 quarters. The position peaked at $1.34M in Q3 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

  • Credit Suisse reported no remaining Ventyx Biosciences position as of Q1 2024 after selling out during the quarter.
  • Credit Suisse sold 43,918 Ventyx Biosciences shares in Q1 2024, an estimated $108K.
  • Credit Suisse first reported a position in Ventyx Biosciences in Q2 2022 and held it in 7 quarters.
  • Credit Suisse's Ventyx Biosciences position peaked at $1.34M in Q3 2023.
  • 126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.